Holen Sie sich die Stockscreener-App
18.54
1.17%
-0.22
Handel nachbörslich:
18.39
-0.15
-0.81%
Schlusskurs vom Vortag:
$18.76
Offen:
$18.64
24-Stunden-Volumen:
3.29M
Relative Volume:
1.41
Marktkapitalisierung:
$1.88B
Einnahmen:
$352.57M
Nettoeinkommen (Verlust:
$-143.01M
KGV:
-10.24
EPS:
-1.81
Netto-Cashflow:
$-153.40M
1W Leistung:
+10.03%
1M Leistung:
-3.03%
6M Leistung:
-29.88%
1J Leistung:
-23.01%
1-Tages-Spanne:
$17.74
$18.69
1-Wochen-Bereich:
$16.02
$20.22
52-Wochen-Spanne:
$13.53
$35.25
Beam Therapeutics Inc Stock (BEAM) Company Profile
Firmenname
Beam Therapeutics Inc
Sektor
Branche
Telefon
857-327-8775
Adresse
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Vergleichen Sie BEAM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc
|
18.54 | 1.65B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-10 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-08 | Herabstufung | Jefferies | Buy → Hold |
| 2023-10-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-02-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-20 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | Eingeleitet | Citigroup | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2022-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-05 | Eingeleitet | Guggenheim | Buy |
| 2021-10-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Fortgesetzt | Stifel | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-11 | Eingeleitet | Redburn | Buy |
| 2021-05-04 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-02-16 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-01-06 | Eingeleitet | Stifel | Hold |
| 2020-08-05 | Eingeleitet | William Blair | Outperform |
| 2020-03-02 | Eingeleitet | Barclays | Overweight |
| 2020-03-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-02 | Eingeleitet | Jefferies | Buy |
| 2020-03-02 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Beam Therapeutics Inc Aktie (BEAM) Neueste Nachrichten
Beam Therapeutics’ Strategic Position in Base Editing and Pipeline Progress - AInvest
Beam Therapeutics’ Unexpected Surge: Analyzing the Latest Performance - StocksToTrade
US Stocks Recap: Will Beam Therapeutics Inc. benefit from AI trendsMarket Trend Summary & Reliable Breakout Forecasts - khodrobank.com
Beam Therapeutics’ Stock Soars as Cathie Wood’s ARK Buys Shares - timothysykes.com
Can technical indicators confirm Beam Therapeutics Inc.’s reversalJuly 2025 Action & Target Return Focused Picks - Newser
Beam Therapeutics Surges 13% on Intraday Rally – What’s Fueling the Momentum? - AInvest
Is this a good reentry point in Beam Therapeutics IncTrade Risk Report & AI Based Buy and Sell Signals - Newser
Applying Elliott Wave Theory to Beam Therapeutics Inc.July 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Intraday pattern recognizer results for Beam Therapeutics IncJuly 2025 Setups & AI Forecast Swing Trade Picks - Newser
Can trapped investors hope for a rebound in Beam Therapeutics IncWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Combining price and volume data for Beam Therapeutics Inc.Weekly Stock Recap & High Yield Equity Trading Tips - Newser
Is this a good reentry point in Beam Therapeutics Inc.Trade Exit Summary & Weekly Breakout Watchlists - Newser
Can Beam Therapeutics Inc. recover in the next quarter2025 Major Catalysts & Consistent Profit Alerts - Newser
Detecting price anomalies in Beam Therapeutics Inc. with AIJuly 2025 Chart Watch & AI Forecasted Entry and Exit Points - Newser
Intraday pattern recognizer results for Beam Therapeutics Inc.2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Is Beam Therapeutics Inc. forming a reversal patternJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Market reaction to Beam Therapeutics Inc.’s recent news2025 Buyback Activity & Reliable Momentum Entry Alerts - Newser
Beam Therapeutics Inc. stock outlook for YEARInsider Buying & High Conviction Investment Ideas - Newser
Understanding Beam Therapeutics Inc.’s price movement2025 Macro Impact & Free Safe Capital Growth Stock Tips - Newser
Risk adjusted return profile for Beam Therapeutics Inc. analyzedLong Setup & Accurate Entry/Exit Alerts - Newser
Applying Wyckoff theory to Beam Therapeutics Inc. stockTrend Reversal & High Accuracy Buy Signal Tips - Newser
Is Beam Therapeutics Inc. trading at a discountSell Signal & Weekly Top Gainers Alerts - khodrobank.com
Does Beam Therapeutics Inc. align with a passive investing strategy2025 Top Gainers & Risk Controlled Stock Alerts - khodrobank.com
What are Beam Therapeutics Inc.’s earnings expectationsJuly 2025 Reactions & Consistent Growth Equity Picks - khodrobank.com
How to manage a losing position in Beam Therapeutics Inc.2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Analyzing Beam Therapeutics Inc. with multi timeframe chartsJuly 2025 Catalysts & Weekly Momentum Picks - Newser
What high frequency data says about Beam Therapeutics Inc.2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Does Beam Therapeutics Inc. have a sustainable dividendJuly 2025 Market Mood & Breakout Confirmation Trade Signals - khodrobank.com
Beam Therapeutics Inc. stock trendline breakdownWeekly Profit Analysis & High Return Stock Watch Alerts - Newser
Will Beam Therapeutics Inc. benefit from geopolitical trendsJuly 2025 PreEarnings & High Return Stock Watch Alerts - khodrobank.com
Analyzing net buyer seller activity in Beam Therapeutics Inc.Trade Exit Summary & Detailed Earnings Play Alerts - Newser
What MACD and RSI say about Beam Therapeutics Inc.Weekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
Is Beam Therapeutics Inc. stock bottoming outMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
Can trapped investors hope for a rebound in Beam Therapeutics Inc.2025 Trading Volume Trends & High Accuracy Swing Trade Signals - Newser
Best data tools to analyze Beam Therapeutics Inc. stockJuly 2025 Opening Moves & High Conviction Buy Zone Alerts - Newser
Chart based analysis of Beam Therapeutics Inc. trends2025 Price Targets & Low Risk Growth Stock Ideas - Newser
Sentiment analysis tools applied to Beam Therapeutics Inc.Earnings Risk Report & Community Verified Swing Trade Signals - Newser
Using flow based indicators on Beam Therapeutics Inc.CEO Change & Daily Profit Maximizing Tips - Newser
How to contact the Daily Bulletin - FinancialContent
Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Beam Therapeutics Inc-Aktie (BEAM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Simon Amy | Chief Medical Officer |
Jul 03 '25 |
Sale |
20.12 |
876 |
17,625 |
64,864 |
| Simon Amy | Chief Medical Officer |
Jul 01 '25 |
Sale |
16.94 |
374 |
6,336 |
65,740 |
| Bellon Christine | Chief Legal Officer |
Apr 01 '25 |
Sale |
18.35 |
5,674 |
104,122 |
117,294 |
| Evans John M. | CEO |
Apr 01 '25 |
Sale |
18.35 |
30,663 |
562,684 |
986,249 |
| Ciaramella Giuseppe | President |
Apr 01 '25 |
Sale |
18.35 |
7,434 |
136,418 |
190,216 |
| Cavanagh Bethany J | SVP, Finance and Treasurer |
Apr 01 '25 |
Sale |
18.35 |
3,015 |
55,330 |
44,512 |
| Simon Amy | Chief Medical Officer |
Apr 02 '25 |
Sale |
17.73 |
20,997 |
372,294 |
65,742 |
| Simon Amy | Chief Medical Officer |
Apr 01 '25 |
Sale |
18.35 |
9,566 |
175,542 |
86,739 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):